Examinando por Autor "Akker-Scheek, Inge van den"

Mostrando 1 - 1 de 1
  • No hay miniatura disponible
    Ítem
    ICON 2023: International Scientific Tendinopathy Symposium Consensus – the core outcome set for Achilles tendinopathy (COS-AT) using a systematic review and a Delphi study of professional participants and patients
    (BMJ Publishing Group, 2024-10-22) De Vos, R.-J.; Silbernagel, K.G.; Malliaras, P.; Visser, T.S.; Alfredson, H.; Akker-Scheek, Inge van den; Ark, M. van; Brorsson, A.; Chimenti, R.; Docking, S.; Eliasson, P.; Farnqvist, K.; Haleem, Z.; Hanlon, S.L.; Kaux, J.-F.; Kearney, R.S.; Kirwan, P.D.; Kulig, K.; Kumar, B.; Lewis, T.; Longo, U.G.; Lui, T.H.; Maffulli, N.; Mallows, A.J.; Masci, L.; McGonagle, D.; Morrissey, D.; Murphy, M.C.; Newsham-West, R.; Nilsson-Helander, K.M.; Norris, R.; Oliva, F.; O’Neill, S.; Peers, K.; Rio, E.K.; Sancho Amundarain, Igor ; Scott, A.; Seymore, K.D.; Soh, S.-E.; Vallance, P.; Verhaar, J.A.N.; Vlist, A.C., van der; Weir, A.; Zellers, J.A.; Vicenzino, B.
    To develop a core outcome set for Achilles tendinopathy (COS-AT) for use in clinical trials we performed a five-step process including (1) a systematic review of available outcome measurement instruments, (2) an online survey on truth and feasibility of the available measurement instruments, (3) an assessment of the methodological quality of the selected outcome measurement instruments, (4) an online survey on the outcome measurement instruments as COS and (5) a consensus in-person meeting. Both surveys were completed by healthcare professionals and patients. The Outcome Measures in Rheumatology guidelines with a 70% threshold for consensus were followed. We identified 233 different outcome measurement instruments from 307 included studies; 177 were mapped within the International Scientific Tendinopathy Symposium Consensus core domains. 31 participants (12 patients) completed the first online survey (response rate 94%). 22/177 (12%) outcome measurement instruments were deemed truthful and feasible and their measurement properties were evaluated. 29 participants (12 patients) completed the second online survey (response rate 88%) and three outcome measurement instruments were endorsed: the Victorian Institute of Sports Assessment-Achilles questionnaire, the single-leg heel rise test and evaluating pain after activity using a Visual Analogue Scale (VAS, 0–10). 12 participants (1 patient) attended the final consensus meeting, and 1 additional outcome measurement instrument was endorsed: evaluating pain during activity/loading using a VAS (0–10). It is recommended that the identified COS-AT will be used in future clinical trials evaluating the effectiveness of an intervention. This will facilitate comparing outcomes of intervention strategies, data pooling and further progression of knowledge about AT. As COS-AT is implemented, further evidence on measurement properties of included measures and new outcome measurement instruments should lead to its review and refinement.